Login
Home
Charts
Search
Watchlist
Products

G M Polyplast Ltd

GMPL·BSE
64.000.00%Tue, 22 Sept '26

G M Polyplast Ltd

GMPL
BSE
64.00
0.00%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
86Cr
Close
Close Price
64.00
Industry
Industry
Plastics - Sheets/Films
PE
Price To Earnings
10.41
PS
Price To Sales
0.84
Revenue
Revenue
103Cr
Rev Gr TTM
Revenue Growth TTM
7.12%
PAT Gr TTM
PAT Growth TTM
11.11%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
193330444339434943534558
Growth YoY
Revenue Growth YoY%
-45.216.258.432.145.0-11.6-0.325.5-1.19.54.09.6
Expenses
ExpensesCr
173028404035364537473951
Operating Profit
Operating ProfitCr
232444746667
OPM
OPM%
11.89.97.18.89.110.316.58.613.211.312.512.0
Other Income
Other IncomeCr
001000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000111111111
PBT
PBTCr
233444746657
Tax
TaxCr
010011111111
PAT
PATCr
122332524445
Growth YoY
PAT Growth YoY%
60.748.623.132.743.8-13.4101.2-16.3-28.991.0-3.324.9
NPM
NPM%
7.56.35.96.35.86.211.74.18.47.27.88.2
EPS
EPS
0.01.61.31.80.31.83.81.52.72.82.63.5
QuarterSep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
193330444339434943534558
Growth YoY
Revenue Growth YoY%
-45.216.258.432.145.0-11.6-0.325.5-1.19.54.09.6
Expenses
ExpensesCr
173028404035364537473951
Operating Profit
Operating ProfitCr
232444746667
OPM
OPM%
11.89.97.18.89.110.316.58.613.211.312.512.0
Other Income
Other IncomeCr
001000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000111111111
PBT
PBTCr
233444746657
Tax
TaxCr
010011111111
PAT
PATCr
122332524445
Growth YoY
PAT Growth YoY%
60.748.623.132.743.8-13.4101.2-16.3-28.991.0-3.324.9
NPM
NPM%
7.56.35.96.35.86.211.74.18.47.27.88.2
EPS
EPS
0.01.61.31.80.31.83.81.52.72.82.63.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
4647455568635274829296103
Growth
Revenue Growth%
0.8-4.024.122.8-7.3-17.441.711.411.94.57.1
Expenses
ExpensesCr
444443536559476874818590
Operating Profit
Operating ProfitCr
222234668111213
OPM
OPM%
5.04.63.53.63.95.910.68.29.612.312.112.2
Other Income
Other IncomeCr
000000010000
Interest Expense
Interest ExpenseCr
110000000000
Depreciation
DepreciationCr
010011111111
PBT
PBTCr
111123556101011
Tax
TaxCr
000011112333
PAT
PATCr
110112445778
Growth
PAT Growth%
-19.3-6.695.749.766.153.119.517.444.05.011.1
NPM
NPM%
1.41.11.11.72.03.66.75.76.07.77.78.0
EPS
EPS
624.5504.1471.0922.01,380.414.32.90.43.75.35.56.1
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
4647455568635274829296103
Growth
Revenue Growth%
0.8-4.024.122.8-7.3-17.441.711.411.94.57.1
Expenses
ExpensesCr
444443536559476874818590
Operating Profit
Operating ProfitCr
222234668111213
OPM
OPM%
5.04.63.53.63.95.910.68.29.612.312.112.2
Other Income
Other IncomeCr
000000010000
Interest Expense
Interest ExpenseCr
110000000000
Depreciation
DepreciationCr
010011111111
PBT
PBTCr
111123556101011
Tax
TaxCr
000011112333
PAT
PATCr
110112445778
Growth
PAT Growth%
-19.3-6.695.749.766.153.119.517.444.05.011.1
NPM
NPM%
1.41.11.11.72.03.66.75.76.07.77.78.0
EPS
EPS
624.5504.1471.0922.01,380.414.32.90.43.75.35.56.1

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0000002213131313
Reserves
ReservesCr
233468151912182634
Current Liabilities
Current LiabilitiesCr
1414171919171019119811
Non Current Liabilities
Non Current LiabilitiesCr
221210101111
Total Liabilities
Total LiabilitiesCr
181921252525283937414959
Current Assets
Current AssetsCr
151619222121233230344048
Non Current Assets
Non Current AssetsCr
3324454877812
Total Assets
Total AssetsCr
181921252525283937414959
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
0000002213131313
Reserves
ReservesCr
233468151912182634
Current Liabilities
Current LiabilitiesCr
1414171919171019119811
Non Current Liabilities
Non Current LiabilitiesCr
221210101111
Total Liabilities
Total LiabilitiesCr
181921252525283937414959
Current Assets
Current AssetsCr
151619222121233230344048
Non Current Assets
Non Current AssetsCr
3324454877812
Total Assets
Total AssetsCr
181921252525283937414959

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
421223-4505010
Investing Cash Flow
Investing Cash FlowCr
-100-1-1-10-4-1-2-1-6
Financing Cash Flow
Financing Cash FlowCr
-3-1-11-2-14-21-2-11
Net Cash Flow
Net Cash FlowCr
0002-11-1-101-15
Free Cash Flow
Free Cash FlowCr
421212-51-13-14
CFO To PAT
CFO To PAT%
670.9440.8279.7264.6115.2113.6-122.5129.0-9.468.83.7115.1
CFO To EBITDA
CFO To EBITDA%
180.8103.084.9121.660.269.8-77.689.7-5.942.92.475.7
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
421223-4505010
Investing Cash Flow
Investing Cash FlowCr
-100-1-1-10-4-1-2-1-6
Financing Cash Flow
Financing Cash FlowCr
-3-1-11-2-14-21-2-11
Net Cash Flow
Net Cash FlowCr
0002-11-1-101-15
Free Cash Flow
Free Cash FlowCr
421212-51-13-14
CFO To PAT
CFO To PAT%
670.9440.8279.7264.6115.2113.6-122.5129.0-9.468.83.7115.1
CFO To EBITDA
CFO To EBITDA%
180.8103.084.9121.660.269.8-77.689.7-5.942.92.475.7

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
34351912281107786
Price To Earnings
Price To Earnings
9.78.438.732.214.89.310.4
Price To Sales
Price To Sales
0.70.52.32.51.10.80.8
Price To Book
Price To Book
2.11.77.57.22.81.61.8
EV To EBITDA
EV To EBITDA
6.15.824.220.09.55.86.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
8.28.37.87.28.811.717.214.714.517.418.018.118.1
OPM
OPM%
5.04.63.53.63.95.910.68.29.612.312.112.212.2
NPM
NPM%
1.41.11.11.72.03.66.75.76.07.77.78.08.0
ROCE
ROCE%
37.931.423.218.626.730.128.227.924.931.126.023.123.1
ROE
ROE%
28.018.414.721.524.328.821.420.519.422.319.017.417.4
ROA
ROA%
3.52.72.23.65.49.112.710.713.317.115.313.913.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
34351912281107786
Price To Earnings
Price To Earnings
9.78.438.732.214.89.310.4
Price To Sales
Price To Sales
0.70.52.32.51.10.80.8
Price To Book
Price To Book
2.11.77.57.22.81.61.8
EV To EBITDA
EV To EBITDA
6.15.824.220.09.55.86.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
8.28.37.87.28.811.717.214.714.517.418.018.118.1
OPM
OPM%
5.04.63.53.63.95.910.68.29.612.312.112.212.2
NPM
NPM%
1.41.11.11.72.03.66.75.76.07.77.78.08.0
ROCE
ROCE%
37.931.423.218.626.730.128.227.924.931.126.023.123.1
ROE
ROE%
28.018.414.721.524.328.821.420.519.422.319.017.417.4
ROA
ROA%
3.52.72.23.65.49.112.710.713.317.115.313.913.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
G M Polyplast is a specialist manufacturer that turns raw plastic into high-grade sheets and granules - the essential building blocks that other factories use to make everything from medicine trays to car parts. Founded in 2003 by a veteran with four decades in plastics, the company started as a small manual sheet-maker and has since grown into a vertically integrated operation that makes both the raw material (granules) and the finished sheet, selling to over 1,200 industrial customers across more than ten industries and fifteen countries. The recurring idea that explains its moves is a drive to control more of the value chain - first backward-integrating into granules, then forward into recycled food-grade materials - while staying obsessive about customising products for niche industrial buyers rather than competing on commodity volumes. # Business segments A single, vertically integrated plastic-sheet operation with two production engines - sheet extrusion and granule compounding - that feed each other, plus a sustainability loop that recycles waste back into the same product line. ## 1. Sheet extrusion: the finished surface that industry buys **The company runs over ten high-capacity machines to extrude a wide catalogue of plastic sheets and rolls, selling them to manufacturers who then shape them into final products - from pharmaceutical packaging to bus bodies.** - **A sheet for every use** - the product range spans HIPS (High Impact Polystyrene, a tough, formable plastic), ABS (a rigid, glossy plastic used for durable goods), PET (the clear plastic of water bottles, here sold as sheet rolls), and specialty materials like ESD (electrostatic-discharge) sheets for electronics protection, with a plant capacity of 5,800 metric tonnes per year. - **Customisation is the sales pitch** - rather than selling standard stock, the company formulates sheets to meet a specific customer’s requirement, targeting niche segments where a tailored grade or colour commands better loyalty than a generic product would. - **Sold to factories, not shops** - revenue comes from per-unit B2B sales to manufacturers who use the sheets as raw material; the product is pushed across 15 Indian states and exports to over 15 countries including the UAE, Israel, and Hong Kong, relying solely on traders and vacuum formers for product promotion. - **Quality tested in-house** - a full-fledged lab at the Silvassa factory tests materials after production, backing the ISO 9001 and ISO 22000 certifications that matter to food and pharma clients who need guaranteed, contaminant-free surfaces. ## 2. Compounding: making the raw pellets in-house **Instead of buying all its raw material from the market, the company backward-integrated to manufacture its own premium plastic granules - the tiny pellets that feed its own sheet machines and are also sold directly to other manufacturers.** - **Cheaper, more reliable raw material** - by producing its own ABS and HIPS granules (plus compounds from polyethylene, polypropylene, nylon, and other polymers), the company reduces its dependence on outside suppliers and keeps a two-month safety stock of raw materials, which it says gives it an edge in meeting demand on time when markets are tight. - **A product line of its own** - the granule business is not just an internal supplier; it earns revenue by selling application-specific compounds to industrial clients who use them as the raw material input for their own finished plastic items, effectively making the company a merchant compounder as well as a captive one. - **Stable pricing to build a sticky customer base** - the company supplies granules at constant prices even when raw-material costs swing, a practice it uses to attract and retain a large roster of buyers who value predictable input costs. - **A dedicated subsidiary on the way** - in March 2026, the company incorporated a wholly owned subsidiary, Regranix Private Limited, which will take over the full scope of granule manufacturing, compounding, and recycling, signalling a structural separation of this engine for future scale. ## 3. PET recycling: the closed loop that sells sustainability **The company collects post-consumer PET bottles, washes and crushes them into flakes, and then extrudes those flakes into food-grade R-PET sheets - turning 2,000 tonnes of plastic waste a year into a product that helps its customers meet government recycling mandates.** - **Bottle to sheet, under one roof** - the process starts with baled PET bottles that are sent to a partner washing facility where caps and labels are stripped, the bottles are crushed into flakes, and the flakes are hot- and cold-washed into clear, high-quality raw material; G M Polyplast then combines these flakes with virgin material to extrude 100% food-grade clear sheets for thermoforming companies. - **The regulatory pull is real** - the sheets are sold as Post Consumer Recycled (PCR) and Post Industrial Recycled (PIR) material, which lets corporate clients meet their Extended Producer Responsibility (EPR) obligations - government rules that require a certain percentage of recycled content in plastic packaging. - **Waste comes back again** - the loop extends to collecting leftover trim waste from its thermoforming customers and sending it back for recycling, so the same material can be used multiple times rather than being discarded. - **Powered partly by the sun** - a 35 kVA solar installation at the factory site supports the recycling operation’s energy needs, reinforcing the sustainability claim that the product itself makes. # Group structure and partners **A family-run, single-entity manufacturer that has just created its first subsidiary to house the granule business, with no foreign collaborations and a board split between family and independent directors.** - The company was a standalone entity with no subsidiaries for most of its history, until Regranix Private Limited was incorporated on 13 March 2026 as a wholly owned subsidiary to exclusively handle plastic granule manufacturing and recycling. - It is a family-promoted business: founder Balbirsingh Bholuram Sharma is the father of Managing Director Dinesh Sharma and father-in-law of Executive Director Sarita Sharma, with a six-member board that includes three independent directors. - The company transacts with a related party, ACE Extrusion Private Limited - in which its directors have an interest - for the sale of goods, but has no foreign collaborations or joint ventures.

Documents — G M Polyplast Ltd

  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/bzfn65maz1myg62zg1q4xqpf.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/qrqoquuddbv8blg079lejjiq.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/q3m0l3b1e979k0ub6doc3y52.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/p7gr8cz02gd85nqwhhb91gwk.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/fuajh9w7oumqoso005q8dc6u.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/fpxbmtg08vjzyan0jig7ihzc.pdf
  • Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/hqtbcaiowoe32vo05twt6t1p.pdf
  • Q4 FY2023 Quarterly Result (Mar 2023, PDF): https://www.stockscans.in/document/2qqxafuwn0qmtnjw9f6opn2g.pdf
  • Q2 FY2023 Quarterly Result (Sep 2022, PDF): https://www.stockscans.in/document/34q7wohjwbhtz30ifrwalcf1.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/hzk9mw3kyraikjf8pogyje6m.pdf
  • Q2 FY2023 Investor Presentation (Sep 2022, PDF): https://www.stockscans.in/document/yarkvr2v69qigzvcib5w31du.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/azbl0dixnsakwyxhz29yuemg.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/jpoxh3367sc9qk1zjow65l01.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/hp75yx6oim9ffy0lc9nfcm75.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/n8m74t8kmmz0y68n96ula5yr.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/bksn8jgau50siedc8xv57wu5.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/9414vf5ehqouoror77i0zv0o.pdf

Concall Transcript Summaries — G M Polyplast Ltd

  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/BSE%3AGMPL/transcript-notes/202409/bzfn65maz1myg62zg1q4xqpf.pdf